{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-16T04:26:43.503657+00:00","published_at":"2026-10-15T04:48:17.554305+00:00","section":"events","data":{"state":"PUBLISHED","derivation_version":"alpha-governance-event-derivation-v2","events":[{"event_id":"alpha:event:transition:1u1vdt41mbyplu","event_type":"CEO_CHANGED","effective_at":"2026-03-30","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:geoffrey-dow","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:10"],"evidence_ids":["alpha:projection-evidence:document:25171feed72af2e5884b09cd999f0e5673e02ed232d641d7916b4b7c67398e96"],"summary":"Geoffrey Dow executive of 60 DEGREES PHARMACEUTICALS, INC., effective 2026-03-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:9t9ovnio42x9","event_type":"EXECUTIVE_APPOINTED","effective_at":"2026-03-30","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:kristen-landon","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:11"],"evidence_ids":["alpha:projection-evidence:document:5d255c60bd5e0af0200184ec52ad12de461b7fe554eb86e8b0aaceee8aba7533"],"summary":"Kristen Landon executive of 60 DEGREES PHARMACEUTICALS, INC., effective 2026-03-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:67a49x15zfuxr","event_type":"CFO_CHANGED","effective_at":"2026-03-30","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:tim-miller","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:12"],"evidence_ids":["alpha:projection-evidence:document:f7c265fa61202abeb00e450e7dfc0c757e7ae8132f8b11ad023eb8e3ea370698"],"summary":"Theodore C. Miller executive of 60 DEGREES PHARMACEUTICALS, INC., effective 2026-03-30.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:k4ty216ynjpu","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:charles-allen","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Charles Allen seat on 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1ne64zbxwd9p9","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:cheryl-xu","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:6"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Cheryl Xu seat on 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:4x6v0t1t4sv6r","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:paul-field","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Paul Field seat on 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:fwyeei1izv3eu","event_type":"DIRECTOR_APPOINTED","effective_at":"2023-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:stephen-toovey","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Stephen Toovey seat on 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:ugzpjw121j286","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:committee:60-degrees-pharmaceuticals-inc:audit-chair-compensation-nominating-and-governance","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Audit · Chair; Compensation; Nominating and Governance committee of 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1fg357i16m5p0a","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:charles-allen","alpha:committee:60-degrees-pharmaceuticals-inc:audit-chair-compensation-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:5"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Charles Allen member of Audit · Chair; Compensation; Nominating and Governance, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:908ued4yrad7","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:committee:60-degrees-pharmaceuticals-inc:audit-compensation-chair-nominating-and-governance","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Audit; Compensation · Chair; Nominating and Governance committee of 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:q29vjh1v9wbub","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:paul-field","alpha:committee:60-degrees-pharmaceuticals-inc:audit-compensation-chair-nominating-and-governance"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:8"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Paul Field member of Audit; Compensation · Chair; Nominating and Governance, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:1odm4881ss8c2a","event_type":"COMMITTEE_CREATED","effective_at":"2023-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:committee:60-degrees-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Audit; Compensation; Nominating and Governance · Chair committee of 60 DEGREES PHARMACEUTICALS, INC., effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:30qlm45aukh6","event_type":"COMMITTEE_MEMBER_ADDED","effective_at":"2023-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:stephen-toovey","alpha:committee:60-degrees-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:9"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Stephen Toovey member of Audit; Compensation; Nominating and Governance · Chair, effective 2023-01-01.","derivation":"temporal_relationship_change"},{"event_id":"alpha:event:transition:p3j4b1bgwqx5","event_type":"DIRECTOR_APPOINTED","effective_at":"2022-01-01","detected_at":"2026-10-15T04:48:17.554305+00:00","subject_ids":["alpha:person:geoffrey-dow","alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f"],"caused_claim_ids":["alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:7"],"evidence_ids":["alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb"],"summary":"Geoffrey Dow seat on 60 DEGREES PHARMACEUTICALS, INC., effective 2022-01-01.","derivation":"temporal_relationship_change"}]},"claims":[{"id":"alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:5","subject_id":"alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:charles-allen","object_label":"Charles Allen","object_source_name_forms":[],"value":"Charles Allen: Director, Audit · Chair; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:charles-allen","name":"Charles Allen"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-15T04:48:17.554305+00:00","sources":[{"id":"alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"60 DEGREES PHARMACEUTICALS, INC. DEF 14A 2025-08-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","source_date":"2025-08-27","retrieved_at":"2026-04-28T22:50:09.495+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-27","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-15T04:48:17.554305+00:00","reviewed_at":"2026-10-15T04:48:17.554305+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:6","subject_id":"alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:cheryl-xu","object_label":"Cheryl Xu","object_source_name_forms":[],"value":"Cheryl Xu: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:cheryl-xu","name":"Cheryl Xu"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-15T04:48:17.554305+00:00","sources":[{"id":"alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"60 DEGREES PHARMACEUTICALS, INC. DEF 14A 2025-08-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","source_date":"2025-08-27","retrieved_at":"2026-04-28T22:50:09.495+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-27","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-15T04:48:17.554305+00:00","reviewed_at":"2026-10-15T04:48:17.554305+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:7","subject_id":"alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:geoffrey-dow","object_label":"Geoffrey Dow","object_source_name_forms":[],"value":"Geoffrey Dow: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:geoffrey-dow","name":"Geoffrey Dow"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2022-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2022-01-01","valid_to":null,"recorded_at":"2026-10-15T04:48:17.554305+00:00","sources":[{"id":"alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"60 DEGREES PHARMACEUTICALS, INC. DEF 14A 2025-08-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","source_date":"2025-08-27","retrieved_at":"2026-04-28T22:50:09.495+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-27","effective_from":"2022-01-01","effective_until":null,"observed_at":"2026-10-15T04:48:17.554305+00:00","reviewed_at":"2026-10-15T04:48:17.554305+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:8","subject_id":"alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:paul-field","object_label":"Paul Field","object_source_name_forms":[],"value":"Paul Field: Director, Audit; Compensation · Chair; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:paul-field","name":"Paul Field"},"title":"Director","role_category":"director","committee":"Audit; Compensation · Chair; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-15T04:48:17.554305+00:00","sources":[{"id":"alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"60 DEGREES PHARMACEUTICALS, INC. DEF 14A 2025-08-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","source_date":"2025-08-27","retrieved_at":"2026-04-28T22:50:09.495+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-27","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-15T04:48:17.554305+00:00","reviewed_at":"2026-10-15T04:48:17.554305+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:9","subject_id":"alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:stephen-toovey","object_label":"Stephen Toovey","object_source_name_forms":[],"value":"Stephen Toovey: Director, Audit; Compensation; Nominating and Governance · Chair","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:stephen-toovey","name":"Stephen Toovey"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance · Chair","is_board_chair":false,"is_independent":true,"start_date":"2023-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2023-01-01","valid_to":null,"recorded_at":"2026-10-15T04:48:17.554305+00:00","sources":[{"id":"alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"60 DEGREES PHARMACEUTICALS, INC. DEF 14A 2025-08-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","source_date":"2025-08-27","retrieved_at":"2026-04-28T22:50:09.495+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-08-27","effective_from":"2023-01-01","effective_until":null,"observed_at":"2026-10-15T04:48:17.554305+00:00","reviewed_at":"2026-10-15T04:48:17.554305+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:10","subject_id":"alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:geoffrey-dow","object_label":"Geoffrey Dow","object_source_name_forms":[],"value":"Geoffrey Dow: Chief Executive Officer, President and Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:geoffrey-dow","name":"Geoffrey Dow"},"title":"Chief Executive Officer, President and Director","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-15T04:48:17.554305+00:00","sources":[{"id":"alpha:projection-evidence:document:25171feed72af2e5884b09cd999f0e5673e02ed232d641d7916b4b7c67398e96","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SXTP 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T08:54:21.465009+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-15T04:48:17.554305+00:00","reviewed_at":"2026-10-15T04:48:17.554305+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:11","subject_id":"alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:kristen-landon","object_label":"Kristen Landon","object_source_name_forms":[],"value":"Kristen Landon: Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:kristen-landon","name":"Kristen Landon"},"title":"Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-15T04:48:17.554305+00:00","sources":[{"id":"alpha:projection-evidence:document:5d255c60bd5e0af0200184ec52ad12de461b7fe554eb86e8b0aaceee8aba7533","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SXTP 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T08:54:22.367688+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-15T04:48:17.554305+00:00","reviewed_at":"2026-10-15T04:48:17.554305+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:12add3a6-8322-418a-86c4-ae142e1f555f:leadership_role:12","subject_id":"alpha:company:12add3a6-8322-418a-86c4-ae142e1f555f","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:tim-miller","object_label":"Theodore C. Miller","object_source_name_forms":[],"value":"Theodore C. Miller: Chief Financial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:tim-miller","name":"Theodore C. Miller"},"title":"Chief Financial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-15T04:48:17.554305+00:00","sources":[{"id":"alpha:projection-evidence:document:f7c265fa61202abeb00e450e7dfc0c757e7ae8132f8b11ad023eb8e3ea370698","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SXTP 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T08:54:21.875798+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-15T04:48:17.554305+00:00","reviewed_at":"2026-10-15T04:48:17.554305+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:0f247b1344d6a30c1ede322f04dbc49c618fb15dc9b24a786685646f8e3673eb","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"60 DEGREES PHARMACEUTICALS, INC. DEF 14A 2025-08-27","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000121390025080878/ea0254708-def14a_60degrees.htm","source_date":"2025-08-27","retrieved_at":"2026-04-28T22:50:09.495+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:25171feed72af2e5884b09cd999f0e5673e02ed232d641d7916b4b7c67398e96","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SXTP 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T08:54:21.465009+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:5d255c60bd5e0af0200184ec52ad12de461b7fe554eb86e8b0aaceee8aba7533","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SXTP 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T08:54:22.367688+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:f7c265fa61202abeb00e450e7dfc0c757e7ae8132f8b11ad023eb8e3ea370698","identity_scope":"source_document_reference","source_type":"sec_filing","title":"SXTP 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/1946563/000155485526000467/sxtp-20251231.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T08:54:21.875798+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.829,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.87,"cross_source_agreement":0.75,"temporal_completeness":0.471},"diagnostics":{"published_claims":25,"factual_claims":25,"claims_with_linked_evidence":25,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":17,"temporal_claims_with_valid_from":8,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-15T04:48:17.554305+00:00","observed_at":"2026-10-15T04:48:17.554305+00:00","reviewed_at":"2026-10-15T04:48:17.554305+00:00","verified_at":"2026-10-15T04:48:17.554305+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":25,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/60-degrees-pharmaceuticals-inc/events","section":"events","href":"https://registry.alpha.ac/api/public/companies/60-degrees-pharmaceuticals-inc?format=record&section=events","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}